CD8A and neoplasm: Intratumoral delivery of the nanovaccine altered cytokine expression in myeloid cells, reinforced the CXCL9-CD8+ T/IFNγ feedback loop and reversed the immunosuppressive microenvironment, which led to a significantly higher number of infiltrating T cells for tumor eradication.